Literature DB >> 19527322

Adrenal venous sampling for primary aldosteronism and clinical outcomes after unilateral adrenalectomy: a single-center experience.

Miho Murashima1, Scott O Trerotola, Douglas L Fraker, Dale Han, Raymond R Townsend, Debbie L Cohen.   

Abstract

Adrenal venous sampling (AVS) remains controversial in the management of primary aldosteronism. Retrospective chart review was conducted at the Hospital of the University of Pennsylvania from July 2001 to September 2007. A total of 113 patients underwent AVS, 16 patients were excluded as records were unavailable. Among 97 remaining patients, 61 had unilateral disease and 57 underwent unilateral adrenalectomy. Blood pressure (BP) improved significantly with less antihypertensive medication requirement. Among those with different BP responses to adrenalectomy (cure, improvement, or no change), a higher number of preoperative antihypertensive medications was associated with persistent hypertension (P = .03). There were no significant differences in age (P = .14), duration of hypertension (P = .60), family history of hypertension (P = .68), or serum creatinine (P = .34). When AVS shows lateralization, age, duration of hypertension, family history, or renal dysfunction did not predict BP response to adrenalectomy. Results suggest that these factors should not preclude AVS and subsequent adrenalectomy. Further studies are indicated to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527322      PMCID: PMC8673066          DOI: 10.1111/j.1751-7176.2009.00120.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

1.  Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.

Authors:  Mari K Nishizaka; Monique Pratt-Ubunama; Mohammad A Zaman; Stacey Cofield; David A Calhoun
Journal:  Am J Hypertens       Date:  2005-06       Impact factor: 2.689

Review 2.  Primary aldosteronism: diagnostic and treatment strategies.

Authors:  Cecilia Mattsson; William F Young
Journal:  Nat Clin Pract Nephrol       Date:  2006-04

3.  Laparoscopic adrenalectomy for primary hyperaldosteronism: clinical experience with 60 cases.

Authors:  Masao Tsujihata; Norio Nonomura; Akira Tsujimura; Kazuo Nishimura; Kazuhiro Yoshimura; Akihiko Okuyama
Journal:  J Endourol       Date:  2006-04       Impact factor: 2.942

Review 4.  Primary hyperaldosteronism secondary to unilateral adrenal hyperplasia: an unusual cause of surgically correctable hypertension. A review of 30 cases.

Authors:  Brian K P Goh; Yeh-Hong Tan; Kenneth T E Chang; Peter H K Eng; Sidney K H Yip; Christopher W S Cheng
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

5.  Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.

Authors:  Gary L Schwartz; Stephen T Turner
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

6.  Primary aldosteronism: factors associated with normalization of blood pressure after surgery.

Authors:  A M Sawka; W F Young; G B Thompson; C S Grant; D R Farley; C Leibson; J A van Heerden
Journal:  Ann Intern Med       Date:  2001-08-21       Impact factor: 25.391

7.  Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.

Authors:  Gilberta Giacchetti; Vanessa Ronconi; Giulio Lucarelli; Marco Boscaro; Franco Mantero
Journal:  J Hypertens       Date:  2006-04       Impact factor: 4.844

8.  Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism.

Authors:  M Sywak; J L Pasieka
Journal:  Br J Surg       Date:  2002-12       Impact factor: 6.939

9.  Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Enrico Agabiti-Rosei; Achille C Pessina; Franco Mantero
Journal:  Hypertension       Date:  2007-06-25       Impact factor: 10.190

Review 10.  Detecting and treating primary aldosteronism: primary aldosteronism.

Authors:  F Mantero; M J Mattarello; N M E Albiger
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-03       Impact factor: 2.949

View more
  9 in total

1.  Outcome of surgery for primary hyperaldosteronism.

Authors:  Jens Waldmann; Lisa Maurer; Julia Holler; Peter H Kann; Annette Ramaswamy; Detlef K Bartsch; Peter Langer
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

2.  Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism.

Authors:  M Tagawa; M Ghosn; H Wachtel; D Fraker; R R Townsend; S Trerotola; D L Cohen
Journal:  J Hum Hypertens       Date:  2017-01-12       Impact factor: 3.012

3.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

4.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

5.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

6.  Primary aldosteronism: from case detection to histopathology with up to 6 years of follow-up.

Authors:  Gudbjörg Jonsdottir; Jon Gudmundsson; Gudjon Birgisson; Helga Agusta Sigurjonsdottir
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-23       Impact factor: 3.738

7.  Factors Associated with Resolution of Hypertension after Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Wann Jia Loh; Dawn Shao Ting Lim; Lih Ming Loh; Peng Chin Kek
Journal:  Endocrinol Metab (Seoul)       Date:  2018-08-14

8.  Predictive factors of clinical success after adrenalectomy in primary aldosteronism: A systematic review and meta-analysis.

Authors:  Worapaka Manosroi; Pichitchai Atthakomol; Phichayut Phinyo; Piti Inthaphan
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

9.  High-probability features of primary aldosteronism may obviate the need for confirmatory testing without increasing false-positive diagnoses.

Authors:  Gregory A Kline; Janice L Pasieka; Adrian Harvey; Benny So; Val C Dias
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-27       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.